InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Climaco John M, Chairman & CEO. Director active across 1 company, notably CNS Pharmaceuticals, Inc.. Aggregated, 3 filings have been logged. History available since 16 November 2021. The latest transaction was disclosed on 7 March 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations3 total
35,000 shares@ US$0.2810.23% mcap44.5% of flowCommon StockSEC:0001683168-22-001495:0
5,000 shares@ US$1.28100.0% of flowCommon StockSEC:0001683168-21-005823
5,000 shares@ US$1.280.14% mcap27.7% of flowCommon StockSEC:0001683168-21-005823:0
3 of 3 declarations
About Climaco John M
John M. Climaco is the Chief Executive Officer of CNS Pharmaceuticals, Inc. He leads the company with a strategic vision focused on innovation in the pharmaceutical field. His role includes overseeing operations and developing new initiatives to improve patient health. His experience in the pharmaceutical industry is a major asset for the company.
